Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10799930rdf:typepubmed:Citationlld:pubmed
pubmed-article:10799930lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:10799930lifeskim:mentionsumls-concept:C0039445lld:lifeskim
pubmed-article:10799930lifeskim:mentionsumls-concept:C0036426lld:lifeskim
pubmed-article:10799930pubmed:issue1lld:pubmed
pubmed-article:10799930pubmed:dateCreated2000-7-10lld:pubmed
pubmed-article:10799930pubmed:abstractTextWe report the cases of two women with Rendu-Osler-Weber disease and severe epistaxis. After several procedures failed (electrocoagulation, vascular clamping, dermoplasty, embolization), submucosal infiltration of a sclerosant was performed using the new product etoxysclerol. Epistaxis remained under control after two years of monitoring.lld:pubmed
pubmed-article:10799930pubmed:languagespalld:pubmed
pubmed-article:10799930pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10799930pubmed:citationSubsetIMlld:pubmed
pubmed-article:10799930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10799930pubmed:statusMEDLINElld:pubmed
pubmed-article:10799930pubmed:issn0001-6519lld:pubmed
pubmed-article:10799930pubmed:authorpubmed-author:MartínGGlld:pubmed
pubmed-article:10799930pubmed:authorpubmed-author:RamírezBBlld:pubmed
pubmed-article:10799930pubmed:authorpubmed-author:MarcosMMlld:pubmed
pubmed-article:10799930pubmed:authorpubmed-author:MoraisDDlld:pubmed
pubmed-article:10799930pubmed:authorpubmed-author:CondadoM AMAlld:pubmed
pubmed-article:10799930pubmed:authorpubmed-author:PoncelaMMlld:pubmed
pubmed-article:10799930pubmed:issnTypePrintlld:pubmed
pubmed-article:10799930pubmed:volume51lld:pubmed
pubmed-article:10799930pubmed:ownerNLMlld:pubmed
pubmed-article:10799930pubmed:authorsCompleteYlld:pubmed
pubmed-article:10799930pubmed:pagination36-9lld:pubmed
pubmed-article:10799930pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10799930pubmed:meshHeadingpubmed-meshheading:10799930...lld:pubmed
pubmed-article:10799930pubmed:meshHeadingpubmed-meshheading:10799930...lld:pubmed
pubmed-article:10799930pubmed:meshHeadingpubmed-meshheading:10799930...lld:pubmed
pubmed-article:10799930pubmed:meshHeadingpubmed-meshheading:10799930...lld:pubmed
pubmed-article:10799930pubmed:meshHeadingpubmed-meshheading:10799930...lld:pubmed
pubmed-article:10799930pubmed:meshHeadingpubmed-meshheading:10799930...lld:pubmed
pubmed-article:10799930pubmed:meshHeadingpubmed-meshheading:10799930...lld:pubmed
pubmed-article:10799930pubmed:meshHeadingpubmed-meshheading:10799930...lld:pubmed
pubmed-article:10799930pubmed:meshHeadingpubmed-meshheading:10799930...lld:pubmed
pubmed-article:10799930pubmed:meshHeadingpubmed-meshheading:10799930...lld:pubmed
pubmed-article:10799930pubmed:articleTitle[A new sclerosant for the treatment of Rendu-Osler-Weber disease].lld:pubmed
pubmed-article:10799930pubmed:affiliationServicio de ORL, Hospital Clínico Universitario, Valladolid, España.lld:pubmed
pubmed-article:10799930pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10799930pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:10799930pubmed:publicationTypeCase Reportslld:pubmed